Page 86 - TD-3-4
P. 86
Tumor Discovery RNA-protein complexes deregulated in cancer
2013;8(12):e84060. Cancer. 2020;19:64.
doi: 10.1371/journal.pone.0084060 doi: 10.1186/s12943-020-01159-9
22. Ukmar-Godec T, Wegmann S, Zweckstetter M. Biomolecular 33. Gibson BA, Doolittle LK, Schneider WG, Gerlich DW,
condensation of the microtubule-associated protein tau. Redding S, Rosen MK. Organization of chromatin by intrinsic
Semin Cell Dev Biol. 2020;99:202-214. and regulated phase separation. Cell. 2019;179:470-484.
doi: 10.1016/j.semcdb.2019.06.007 doi: 10.1016/j.cell.2019.08.037
23. Ukmar-Godec T, Hutten S, Grieshop MP, et al. Lysine/RNA- 34. Nylund P, Garrido-Zabala B, Kalushkova A, Wiklund HJ. The
interactions drive and regulate biomolecular condensation. complex nature of lncRNA-mediated chromatin dynamics
Nat Commun. 2019;10(1):2909. in multiple myeloma. Front Oncol. 2023;13:1303677.
doi: 10.1038/s41467-019-10792-y doi: 10.3389/fonc.2023.1303677
24. Boyko S, Surewicz WK. Tau liquid-liquid phase 35. Hu WL, Jin L, Xu A, et al. GUARDIN is a p53-responsive
separation in neurodegenerative diseases. Trends Cell Biol. long noncoding RNA that is essential for genomic stability.
2022;32(7):611-623. Nat Cell Biol. 2018;20:492-502.
doi: 10.1016/j.tcb.2022.01.011 doi: 10.1038/s41556-018-0066-7
25. Abasi LS, Elathram N, Movva M, Deep A, Corbett KD, 36. Kurup JT, Kidder BL. Identification of H4K20 me3-and
Debelouchina GT. Phosphorylation regulates tau’s phase H3K4 me3-associated RNAs using CARIP-Seq expands the
separation behavior and interactions with chromatin. transcriptional and epigenetic networks of embryonic stem
Commun Biol. 2024;7(1):251. cells. J Biol Chem. 2018;293(39):15120-15135.
doi: 10.1038/s42003-024-05920-4 doi: 10.1074/jbc.RA118.004974
26. Parolini F, Tira R, Barracchia CG, et al. Ubiquitination of 37. Agredo A, Kasinski AL. Histone 4 lysine 20 tri-methylation:
Alzheimer’s-related tau protein affects the liquid-liquid A key epigenetic regulator of chromatin structure and
phase separation in a site- and cofactor-dependent manner. disease. Front Genet. 2023;14:1243395.
Int J Biol Macromol. 2022;201:173-181.
doi: 10.3389/fgene.2023.1243395
doi: 10.1016/j.ijbiomac.2021.12.191
38. Fan L, Sun W, Lyu Y, et al. Chrom-seq identifies RNAs at
27. Farooqi AA, Fayyaz S, Poltronieri P, Calin G, Mallardo M. chromatin marks. Sci Adv. 2024;10(31):eadn1397.
Epigenetic deregulation in cancer: Enzyme players and doi: 10.1126/sciadv.adn1397
noncoding RNAs. Semin Cancer Biol. 2022;83:197-207.
39. Ahmad A, Poltronieri P, Uddin S. Editorial: LncRNAs in
doi: 10.1016/j.semcancer.2020.07.013
cancer metastasis and therapy resistance. Front Oncol.
28. Mattick JS, Amaral PP, Carninci P, et al. Long 2021;11:813274.
noncoding RNAs: Definitions, functions, challenges and doi: 10.3389/fonc.2021.813274
recommendations. Nat Rev Mol Cell Biol. 2023;24:430-447.
40. Zang C, Nie FQ, Wang Q, et al. Long noncoding RNA
doi: 10.1038/s41580-022-00566-8
LINC01133 represses KLF2, P21 and E-cadherin
29. Poltronieri P. Regulatory RNAs: Role as scaffolds assembling transcription through binding with EZH2 and LSD1 in non-
protein complexes and their epigenetic deregulation. Explor small cell lung cancer. Oncotarget. 2016;7:11696-11707.
Target Antitumor Ther. 2024;5(4):841-876.
doi: 10.18632/oncotarget.7077
doi: 10.37349/etat.2024.00252
41. Kong Y, Hsieh CH, Alonso LC. ANRIL: A lncRNA at the
30. Cusenza VY, Tameni A, Neri A, Frazzi R. lncRNA epigenetics: CDKN2A/B locus with roles in cancer and metabolic
The significance of m6A and m5C lncRNA modifications in disease. Front Endocrinol (Lausanne). 2018;9:405.
cancer. Front Oncol. 2023;13:1063636.
doi: 10.3389/fendo.2018.00405
doi: 10.3389/fonc.2023.1063636
42. Lian Y, Yan C, Ding J, et al. A novel lncRNA, LL22NC03-
31. Bure IV, Nemtsova MV, Kuznetsova EB. Histone N64E9.1, represses KLF2 transcription by binding with
modifications and non-coding RNAs: Mutual epigenetic EZH2 in colorectal cancer. Oncotarget. 2017;8:59435-59445.
regulation and role in pathogenesis. Int J Mol Sci. doi: 10.18632/oncotarget.19738
2022;23:5801.
43. Quagliata L, Matter MS, Piscuoglio S, et al. Long
doi: 10.3390/ijms23105801
noncoding RNA HOTTIP/HOXA13 expression is
32. Yang X, Liu M, Li M, et al. Epigenetic modulations of associated with disease progression and predicts the
noncoding RNA: A novel dimension of Cancer biology. Mol outcome in hepatocellular carcinoma patients. Hepatology.
Volume 3 Issue 4 (2024) 27 doi: 10.36922/td.4657

